| Abstract: | ![]()
The use of exogenous oxytocin to induce or augment labor has increased in recent years. This literature‐informed review examines the action of this medication and the potential associated complications, with an evaluation of current professional practice guidelines. A brief history of the use of exogenous oxytocin for labor induction or augmentation is presented. In addition, risk management strategies for the prevention of oxytocin‐related adverse outcomes and subsequent litigation are identified. |
